Global Innovative Platforms Appoints James C Jones to Board

Adds legal, engineering, and corporate governance expertise to support VetBreath Analytics platform development and commercialization

Global Innovative Platforms (OTCMKTS:GIPL)

ORLANDO, FL, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- Global Innovative Platforms Inc. (OTC: GIPL), a reporting company under the Securities Exchange Act of 1934 focused on advancing non-invasive diagnostics in animal health, today announced the appointment of James “Jim” Jones to its Board of Directors, effective April 1, 2026.

Mr. Jones brings a multidisciplinary background as both a registered professional engineer and an attorney, with extensive experience in corporate governance, contract law, and business advisory. His appointment is intended to strengthen the Company’s board oversight capabilities as it continues development and prepares for broader commercialization of its VetBreath™ Analytics platform.

Andrew Brown, Chief Executive Officer of Global Innovative Platforms, stated, “Jim brings a unique combination of technical, legal, and business expertise that is highly relevant as we continue to build our organization. His experience in corporate governance, contracts, and advising growing businesses will help ensure we maintain disciplined execution as we scale.”

James “Jim” Jones – Board of Directors

James “Jim” Jones is a registered professional engineer and attorney with extensive experience in contract law, corporate governance, and business advisory.

Mr. Jones founded and managed a consulting firm that supported a wide range of highly technical projects for clients across the United States, Japan, and Germany. Throughout his career, he has represented numerous clients in legal and business matters and has served as general counsel to a major automobile network for many years.

He has served on multiple corporate boards as well as boards of nonprofit organizations, providing guidance on governance, contracts, and financial oversight. In addition to his board experience, Mr. Jones is an active investor in startup businesses and has provided business development consulting to early-stage companies across various industries.

Mr. Jones brings experience across engineering, legal, and financial disciplines, with a focus on supporting organizational growth, managing risk, and strengthening corporate governance frameworks.

Strategic Relevance to Global Innovative Platforms

Global Innovative Platforms is developing the VetBreath™ Analytics platform, a non-invasive diagnostic approach designed to detect disease-associated volatile organic compound (VOC) patterns in animal breath. The platform is initially focused on heartworm detection in dogs, with ongoing development of additional parasite markers and future expansion into broader animal health applications.

As the Company advances its development and commercialization efforts, board-level oversight in areas such as corporate governance, contractual frameworks, and regulatory considerations becomes increasingly important. Mr. Jones’ background in engineering and law is expected to support the Company in navigating these areas while maintaining operational discipline.

About Global Innovative Platforms Inc.

Global Innovative Platforms Inc. (OTC: GIPL) is a reporting company under the Securities Exchange Act of 1934 focused on developing and commercializing non-invasive diagnostic technologies for animal health. Its VetBreath™ Analytics platform is designed to analyze volatile organic compounds in exhaled breath to identify disease-associated patterns, with an initial focus on heartworm and intestinal parasite detection in dogs. The Company is advancing research, validation studies, and commercialization initiatives to support broader adoption across veterinary practices.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, expectations regarding the Company’s strategic initiatives, development and commercialization of its VetBreath™ Analytics platform for non-invasive breath-based diagnostics in animal health (with an initial focus on parasite detection such as heartworm in dogs), potential revenue growth, and use of proceeds from any financing activities. Forward-looking statements are generally identified by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “predict,” and similar expressions, or by statements that events or trends “may,” “will,” or “could” occur.

These forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including but not limited to: the early-stage nature of the Company’s technology and limited operating history; dependence on successful further development, testing, and potential regulatory clearance or commercialization of the VetBreath™ Analytics platform; ability to generate meaningful revenue and achieve profitability; need for additional financing to fund operations and development; competition in the animal health diagnostics market; technological, intellectual property, or execution risks; general economic and market conditions; and other risks described in the Company’s filings with the U.S. Securities and Exchange Commission, including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release and in the Company’s SEC filings. Global Innovative Platforms Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

Roger Hayes
Global Innovative Platforms Inc.
roger@giplinc.com
Visit us on social media:
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.